OpenURL Connection Search

Select item for more details and to access through your institution.

TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
Published in:
PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140694
By:
- Tomkowicz, Brian;
- Walsh, Eileen;
- Cotty, Adam;
- Verona, Raluca;
- Sabins, Nina;
- Kaplan, Fred;
- Santulli-Marotto, Sandy;
- Chin, Chen-Ni;
- Mooney, Jill;
- Lingham, Russell B.;
- Naso, Michael;
- McCabe, Timothy
Publication type:
Article
DLK1: A Novel Target for Immunotherapeutic Remodeling of the Tumor Blood Vasculature.
Published in:
Molecular Therapy, 2013, v. 21, n. 10, p. 1958, doi. 10.1038/mt.2013.133
By:
- Chi Sabins, Nina;
- Taylor, Jennifer L;
- Fabian, Kellsye PL;
- Appleman, Leonard J;
- Maranchie, Jodi K;
- Stolz, Donna Beer;
- Storkus, Walter J
Publication type:
Article
Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4<sup>+</sup> and CD8<sup>+</sup> T cells.
Published in:
Frontiers in Immunology, 2016, p. 1, doi. 10.3389/fimmu.2016.00221
By:
- Sabins, Nina C.;
- Harman, Benjamin C.;
- Barone, Linda R.;
- Shixue Shen;
- Santulli-Marotto, Sandra
Publication type:
Article
Using a wearable patch to develop a digital monitoring biomarker of inflammation in response to LPS challenge.
Published in:
CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13734
By:
- Avey, Stefan;
- Chatterjee, Meenakshi;
- Manyakov, Nikolay V.;
- Cooper, Philip;
- Sabins, Nina;
- Mosca, Kenneth;
- Mori, Simone;
- Baribaud, Frédéric;
- Morris, Mark;
- Lehar, Joseph;
- Deiteren, Annemie;
- Cossu, Marta;
- Smets, Sophie;
- Huizer, Tanja;
- Lamousé‐Smith, Esi;
- Campbell, Kim;
- Pandis, Ioannis
Publication type:
Article
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
Published in:
Journal of Crohn's & Colitis, 2023, v. 17, n. 8, p. 1235, doi. 10.1093/ecco-jcc/jjad047
By:
- Allez, Matthieu;
- Sands, Bruce E;
- Feagan, Brian G;
- D'Haens, Geert;
- Hertogh, Gert De;
- Randall, Charles W;
- Zou, Bin;
- Johanns, Jewel;
- O'Brien, Christopher;
- Curran, Mark;
- Rebuck, Rory;
- Wang, Mei-Lun;
- Sabins, Nina;
- Baker, Thomas;
- Kobayashi, Taku
Publication type:
Article

Found: 5

TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.

DLK1: A Novel Target for Immunotherapeutic Remodeling of the Tumor Blood Vasculature.

Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4<sup>+</sup> and CD8<sup>+</sup> T cells.

Using a wearable patch to develop a digital monitoring biomarker of inflammation in response to LPS challenge.

A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.